| Company Name: |
Nanjing Shizhou Biology Technology Co.,Ltd
|
| Tel: |
13675144456 |
| Email: |
sean.lv@synzest.com |
| Products Intro: |
Product Name:(2E)-3-[5-(4-tert-butylbenzenesulfonamido)-1-benz
othiophen-2-yl]-N-hydroxyprop-2-enamide CAS:1215115-03-9 Purity:95%HPLC Package:500mg;1g;5g;10g
|
| Company Name: |
cjbscvictory
|
| Tel: |
13348960310 13348960310 |
| Email: |
3003867561@qq.com |
| Products Intro: |
Product Name:KH-3 CAS:1215115-03-9 Purity:>=98% Package:5mg10mg20mg0mg100mg00mg1g2g等應(yīng)客戶需求包裝
|
(2E)-3-[5-(4-tert-butylbenzenesulfonamido)-1-benz
othiophen-2-yl]-N-hydroxyprop-2-enamide manufacturers
- KH-3
-
- $1270.00
-
2026-05-11
- CAS:1215115-03-9
- Purity:
- Supply Ability: 10g
|
| | (2E)-3-[5-(4-tert-butylbenzenesulfonamido)-1-benz
othiophen-2-yl]-N-hydroxyprop-2-enamide Basic information |
| | (2E)-3-[5-(4-tert-butylbenzenesulfonamido)-1-benz
othiophen-2-yl]-N-hydroxyprop-2-enamide Chemical Properties |
| density | 1.374±0.06 g/cm3(Predicted) | | pka | 8.39±0.30(Predicted) | | form | Solid | | color | Off-white to light yellow |
| | (2E)-3-[5-(4-tert-butylbenzenesulfonamido)-1-benz
othiophen-2-yl]-N-hydroxyprop-2-enamide Usage And Synthesis |
| Uses | KH-3 is a potent RNA-binding protein Hu antigen R (HuR) inhibitor with an IC50 value of 0.35 μM. KH-3 has anti-proliferative activity. KH-3 suppresses breast cancer cell invasion as well as delays the initiation of lung colonies by disrupting HuR-FOXQ1 mRNA interaction[1]. | | in vivo | KH-3 (100 mg/kg; i.p.; three times a week for three weeks; female athymic NCr-nu/nu mice and BALB/c mice) inhibits breast cancer growth and metastasis in vivo[1]. | Animal Model: | Female athymic NCr-nu/nu mice of MDA-MB-231 orthotopic xenograft and BALB/c mice of MDA-MB-231 orthotopic xenograft[1] | | Dosage: | 100 mg/kg | | Administration: | Intraperitoneal injection; three times a week for three weeks | | Result: | Inhibited tumor growth, resulting in 60% tumor regression after three-week treatment and delayed the initiation of pulmonary metastases.
Reduced the protein expression levels of HuR targets in tumor tissues as well as the induction of E-cadherin expression.
|
| | References | [1] Wu X, et, al. Targeting the interaction between RNA-binding protein HuR and FOXQ1 suppresses breast cancer invasion and metastasis. Commun Biol. 2020 Apr 24;3(1):193. DOI:10.1038/s42003-020-0933-1 |
| | (2E)-3-[5-(4-tert-butylbenzenesulfonamido)-1-benz
othiophen-2-yl]-N-hydroxyprop-2-enamide Preparation Products And Raw materials |
|